Intervention model for detection, prevention and control of COVID-19 in community pharmacy
Metadatos
Afficher la notice complèteAuteur
Cortés Fernández, María Esther; Zarzuelo Romero, María José; Amador Fernández, Noelia; Valverde Merino, María Isabel; Martínez Martínez, FernandoEditorial
Universidad de Sao Paulo
Materia
Intervention Coronavirus COVID-19 Minor ailments Pharmaceutical care
Date
2022-12-19Referencia bibliográfica
Cortés, M. E... [et al.]. Intervention model for detection, prevention and control of COVID-19 in community pharmacy. Braz. J. Pharm. Sci. 58. 2022. [https://doi.org/10.1590/s2175-97902022e20988]
Résumé
The announcement by the WHO of the characterization of the new Coronavirus 2019 disease
(COVID-19) as a pandemic, entails an adaptation by the community pharmacy in carrying out
its care activity in general, with particular emphasis on ”Minor Ailments Service” in particular.
The measures taken by the different health administrations in which patient telephone care by
primary care offices is prioritized have left more consultations on symptoms in the community
pharmacist health-related problems as pharmacies are the closest health facilities to the patient.
The similarity between the symptomatology caused by the new Coronavirus with that of some
Enteroviruses that cause mild respiratory and gastrointestinal tables (dry cough, fever, sore
throat, vomiting, diarrhoea, etc.) makes community pharmacies highly capable places for
contagion detection and prevention. A model of protocolized intervention is needed to facilitate
the pharmacist’s work in discriminating during the indication between minor symptoms and
symptoms of referral for possible cases of COVID-19 so that in conjunction with the rest of the
staff we help control the disease and make better use of primary care consultations.